Exazyme

Exazyme

Biotechnologieforschung

Berlin, BE 3.221 Follower:innen

Redefining Protein Design: Driven by Artificial Intelligence. Guided by Human Ingenuity.

Info

Exazyme’s mission is to make designing chemistry as easy as using an app – facilitating the ideas that shorten the wait to solve the world’s most pressing problems: from CO2 to cancer. With Exazyme’s solution, biotech innovators can discover the best possible protein for their goals while drastically reducing the number of experiments required. They may need 100 times fewer experiments than with standard methods – and achieve superior results. Exazyme is used by protein engineers in the pharmaceutical, industrial biotechnology and green biotechnology industries. The solution helps to design better drugs and therapies, chemicals and food, and improve plant properties for hardiness, productivity, and CO2 absorption. Investors: AIX Ventures, Atlantic Labs Co-financed by the IBB ProFIT program and the European Union (EFRE program). Project: Protein design and molecular design with artificial intelligence Application Numbers: 10196523/10196524

Branche
Biotechnologieforschung
Größe
2–10 Beschäftigte
Hauptsitz
Berlin, BE
Art
Privatunternehmen
Gegründet
2021
Spezialgebiete
biotech, artificial intelligence und protein engineering

Orte

Beschäftigte von Exazyme

Updates

Ähnliche Seiten

Jobs durchsuchen

Finanzierung

Exazyme Insgesamt 1 Finanzierungsrunde

Letzte Runde

Seed

2.174.700,00 $

Weitere Informationen auf Crunchbase